>
Switch to:

Allergy Therapeutics Cash Ratio

: 0.00 (As of Jun. 2021)
View and export this data going back to 2004. Start your Free Trial

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Allergy Therapeutics's Cash Ratio for the quarter that ended in Jun. 2021 was 0.00.

Allergy Therapeutics has a Cash Ratio of 0.00. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Allergy Therapeutics's Cash Ratio or its related term are showing as below:

OTCPK:AGYTF' s Cash Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.52   Max: 4.83
Current: 2.21

0.01
4.83

During the past 13 years, Allergy Therapeutics's highest Cash Ratio was 4.83. The lowest was 0.01. And the median was 0.52.

OTCPK:AGYTF's Cash Ratio is ranked lower than
99.99% of the 15 Companies
in the Drug Manufacturers industry.

( Industry Median: 0.64 vs. OTCPK:AGYTF: 2.21 )

Allergy Therapeutics Cash Ratio Historical Data

The historical data trend for Allergy Therapeutics's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data
Trend Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21
Cash Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.58 1.06 1.63 2.03 2.21

Allergy Therapeutics Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Cash Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Allergy Therapeutics's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Allergy Therapeutics Cash Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, Allergy Therapeutics's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Allergy Therapeutics's Cash Ratio falls into.



Allergy Therapeutics Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Allergy Therapeutics's Cash Ratio for the fiscal year that ended in Jun. 2021 is calculated as:

Cash Ratio (A: Jun. 2021 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=56.483870967742/25.568022440393
=2.21

Allergy Therapeutics's Cash Ratio for the quarter that ended in Jun. 2021 is calculated as:

Cash Ratio (Q: Jun. 2021 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=56.483870967742/25.568022440393
=2.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergy Therapeutics  (OTCPK:AGYTF) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Allergy Therapeutics Cash Ratio Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergy Therapeutics Business Description

Allergy Therapeutics logo
Industry
Traded in Other Exchanges
Address
Dominion Way, Worthing, West Sussex, GBR, BN14 8SA
Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics Headlines

No Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)